Neural Markers of Early Treatment Response During Antidepressant Treatment in Major Depressive Disorder

被引：0
|
作者：
Ramasubbu, Rajamannar [1 ]
Goodyear, Bradley [1 ]
Gaxiola, Ismael [1 ]
MacQueen, Glenda [1 ]
机构：
[1] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
505
引用
收藏
页码：145S / 145S
页数：1
相关论文
共 50 条
  • [21] Personalized antidepressant treatment for patients with major depressive disorder
    Chin, Tracy
    Huyghebaert, Trudy
    Svrcek, Clark
    Oluboka, Oloruntoba
    CANADIAN FAMILY PHYSICIAN, 2022, 68 (11) : E301 - E309
  • [22] Understanding the Antidepressant Debate in the Treatment of Major Depressive Disorder
    Naudet, Florian
    Boussageon, Remy
    Palpacuer, Clement
    Gallet, Laurent
    Reymann, Jean-Michel
    Falissard, Bruno
    THERAPIE, 2015, 70 (04): : 321 - 327
  • [23] Cerebral Blood Perfusion Predicts Response to Antidepressant Treatment in Major Depressive Disorder
    McInnis, Melvin
    Gideon, John
    Khorram, Soheil
    Provost, Emily Mower
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S266 - S266
  • [24] Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder
    Zhou, Qi
    Lv, Xiaozhen
    Zhou, Shuzhe
    Liu, Qi
    Tian, Hongjun
    Zhang, Kerang
    Wei, Jing
    Wang, Gang
    Chen, Qiaoling
    Zhu, Gang
    Wang, Xueyi
    An, Cuixia
    Zhang, Nan
    Huang, Yu
    Si, Tianmei
    Yu, Xin
    Shi, Chuan
    PSYCHIATRY RESEARCH, 2021, 305
  • [25] SUBPHENOTYPES IN MAJOR DEPRESSIVE DISORDER TO BETTER CHARACTERIZE PHARMACOGENOMIC ANTIDEPRESSANT TREATMENT RESPONSE
    Ahmed, A. T.
    Frye, M. A.
    Rush, A.
    Bobo, W. V.
    Biernacka, J.
    Flavin, D. Hall
    Jenkins, G. D.
    Batzle, A.
    Skime, M. K.
    Wang, L.
    Craighead, W.
    Mayberg, H. S.
    Weinshilboum, R. M.
    Kaddurah-Daouk, R. F.
    Dunlop, B. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S19 - S20
  • [26] EPA and DHA as markers of nutraceutical treatment response in major depressive disorder
    Kiki P. van der Burg
    Lachlan Cribb
    Joseph Firth
    Diana Karmacoska
    David Mischoulon
    Gerard J. Byrne
    Chad Bousman
    Con Stough
    Jenifer Murphy
    Georgina Oliver
    Michael Berk
    Chee H. Ng
    Jerome Sarris
    European Journal of Nutrition, 2020, 59 : 2439 - 2447
  • [27] EPA and DHA as markers of nutraceutical treatment response in major depressive disorder
    van der Burg, Kiki P.
    Cribb, Lachlan
    Firth, Joseph
    Karmacoska, Diana
    Mischoulon, David
    Byrne, Gerard J.
    Bousman, Chad
    Stough, Con
    Murphy, Jenifer
    Oliver, Georgina
    Berk, Michael
    Ng, Chee H.
    Sarris, Jerome
    EUROPEAN JOURNAL OF NUTRITION, 2020, 59 (06) : 2439 - 2447
  • [28] Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
    Mauro Garcia-Toro
    Esteban Medina
    Jaime L Galan
    Miguel A Gonzalez
    Jorge Maurino
    BMC Psychiatry, 12
  • [29] Review: an early sustained response can occur in the first and second weeks of antidepressant treatment for major depressive disorder
    Artigas, Francesc
    EVIDENCE-BASED MENTAL HEALTH, 2006, 9 (03) : 78 - 78
  • [30] Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
    Garcia-Toro, Mauro
    Medina, Esteban
    Galan, Jaime L.
    Gonzalez, Miguel A.
    Maurino, Jorge
    BMC PSYCHIATRY, 2012, 12
12345